Cogito

Positioning first — because this listing needs a correction before a review

I want to start where an honest review of this entry has to start: the product described in this catalog record does not match the domain it points to, and a reader who follows the link will not find what the listing promises. The record describes an "AI mental health companion app" with daily check-ins, mood tracking and behavioral health coaching at five dollars a month, on cogito.com. In my checks at the time of writing, cogito.com does not host any AI health product at all — it redirects to shd.solutions, a German IT services company, and the name "Cogito" in AI circles belongs to an entirely different business: Cogito Corporation of Boston, the behavioral-analytics company whose domain is cogitocorp.com, and which was acquired by Verint in October 2024 and now lives at verint.com/cogito. Cogito Corporation did once have a mental-health-adjacent mobile product, Cogito Companion, but as a research collaboration with the US Department of Veterans Affairs, not as a five-dollar consumer subscription. So this review covers what the "Cogito" name actually refers to today, notes where the listing's claims come from, and rates the entry as it stands — because on ToolSpotter the review serves the reader deciding whether to buy, and this reader is currently being sent to the wrong place.

What the real Cogito is

Cogito Corporation, founded in 2007 in Boston with roots in MIT media-lab behavioral research, built emotion AI for contact centers. The technology analyzes hundreds of behavioral signals in voice — pace, pitch, turn-taking, monologue length, vocal stress — and gives call-center agents live prompts during a call: slow down, you are interrupting, the customer's tone has shifted. Alongside the in-call coaching it produces customer- and employee-experience scores per call and supervisor tooling (the Cogito Teams product) for monitoring and coaching at team scale. G2 reviews through 2026 describe exactly this: real-time emotional intelligence cues for agents, empathy and active-listening prompts, burnout detection for agents, CRM and telephony integrations. It is enterprise software — AWS Marketplace listings in 2026 showed roughly $200,000 a year for 100 agents on a twelve-month contract, about $167 per agent per month, and there is no self-serve signup.

Since the Verint acquisition in October 2024 (deal completed 11 October per PitchBook; Crunchbase lists the same acquirer), Cogito has been folded into Verint's CX Automation Platform. cogitocorp.com now 301-redirects to verint.com/cogito, where the Cogito capability appears as Verint's real-time coaching and CX/EX scoring bots among the wider Agent Copilot bot family. The product is not discontinued — the coaching and scoring functionality is being absorbed into a larger suite — but "Cogito" as an independent product you can buy, price and evaluate on its own terms effectively ended in 2024.

Where the mental-health framing comes from

The catalog description is not pure invention, which is why I traced it. Cogito Companion was a real smartphone application developed by Cogito Corporation with a Veterans Affairs Medical Center, documented in the Journal of Medical Internet Research in 2020: it collected passive and active behavioral-health indicators — vocal features, digital phenotyping of everyday social signals — and surfaced them for clinical outreach, with mood and symptom tracking in the interface. It was a feasibility study, and a mixed-methods one at that: the published work evaluates willingness to download and use the app and its acceptability, not a commercial product with a subscription price. Nothing in the study or the company's later history suggests a $5-per-month consumer coaching app ever shipped. If a reader wants an AI-assisted mental well-being app with published clinical evidence today, the closest thing I found under the name COGITO is a free self-help application from the University Medical Center Hamburg-Eppendorf (UKE), based on cognitive-behavioral therapy and metacognitive training, which ran a 213-person randomized trial published in the Journal of Psychiatric Research in 2024 showing improvements in self-esteem and depression outcomes against a wait-list control. That app is free, German in origin, and unrelated to cogito.com or to Cogito Corporation.

My testing notes

There is no product at the listed URL to test, so my hands-on work here was verification, and two observations from it are worth recording. First, the domain check itself: I fetched cogito.com and www.cogito.com directly — the bare HTTP domain redirected to shd.solutions/de/loesungen while the HTTPS host failed to respond in my checks, and cogitocorp.com redirected cleanly to verint.com/cogito. A catalog entry whose link leads to an unrelated German IT firm is not a small editorial problem; it is the kind of error that sends a buyer shopping elsewhere and costs the review its credibility. Second, I read the G2 review corpus for Cogito Corporation through October 2026 to gauge whether the underlying technology is well regarded independent of the listing problem: the pattern is consistent — reviewers value the live behavioral prompts and the scalable coaching angle, and the recurring criticisms are about alert fatigue for agents and the difficulty of proving attribution for outcomes like NPS movement. The Verint-era customer case material (a telco reporting thirty-second call-time reductions and NPS gains) is vendor-published and should be read as such.

If you were looking for the contact-center product instead

Some readers may arrive here actually seeking the Boston company's software, so here is the short buyer's guide to that path. Verint now sells the Cogito capability inside its CX Automation Platform: real-time agent guidance, per-call CX and EX scores, and supervisor coaching, as one bot family among the Agent Copilot bots. Procurement runs through Verint's enterprise sales motion, and the marketplace numbers I found (about $200,000 per year for roughly 100 agents on a twelve-month term) indicate deals sized for large contact centers rather than small teams. The evaluation questions I would bring to that conversation are the ones reviewers keep raising: how the live prompts avoid alert fatigue for agents, how the experience scores integrate with existing QA scorecards rather than replacing them, and what attribution evidence supports the outcomes claims. Emotion-AI coaching has real skeptics in the research literature, and per-call scoring is only as good as the calibration behind it, so ask for a pilot design with a control group before committing to a multi-year enterprise agreement.

What it does not do

Whatever the record says, there is no purchasable AI behavioral-health coaching companion here: no $5 plan, no consumer app, no daily check-ins product at cogito.com. Cogito Corporation's real product never served individuals — it sells to enterprises with contact centers of meaningful size. The Cogito Companion research app is not available for download, and its published evidence is feasibility-level, not efficacy. The UKE COGITO app is real and free but is a structured self-help program — exercises, reminders and mood-related programs — not an AI coaching companion, and it makes no claims to personalized AI behavioral coaching. And as an independent product, Cogito's technology is now inside Verint's platform: pricing is enterprise quote-only through Verint's sales channel, and the standalone evaluation material a reviewer would normally use — an independent product page, a rate card, a changelog — no longer exists in a clean form.

Verdict

I cannot recommend this entry as listed, and my rating reflects the listing as much as the name behind it. The real Cogito technology is credible, well-liked by contact-center reviewers and now embedded in a major CX suite — but that is an enterprise emotion-AI product, not the consumer mental-health companion this record describes, and the URL points at neither. For the buyer seeking AI behavioral-health coaching, the honest answer is that this page does not sell it; the free UKE COGITO app has the published clinical evidence in that space, and the Cogito Companion research line is closed. I rate this entry 1.9 on the rubric: almost nothing of the described core functionality exists at the destination, pricing is unverifiable against any live product, usability is moot when the link fails, and the only mature ecosystem here belongs to a different product in a different market. Fix the record before spending editorial effort on a verdict.

A note on what I could not verify

I could not reach a live product page at cogito.com over HTTPS during my checks (the host did not respond), so it is possible the domain hosts something I could not see. If the catalog's product is a small consumer app that exists behind that domain, I will re-review on evidence; everything I could verify says otherwise.

Sources

• https://www.verint.com/cogito/
• https://cogitocorp.com/
• https://www.contactwithai.com/contact-center/cogito
• https://pitchbook.com/profiles/company/62731-81
• https://www.crunchbase.com/organization/cogito-corp
• https://pmc.ncbi.nlm.nih.gov/articles/PMC7448171
• https://www.jmir.org/2020/8/e15506
• https://pubmed.ncbi.nlm.nih.gov/38670060
• https://play.google.com/store/apps/details?id=de.uke.cogitoapp
• https://www.g2.com/products/cogito-corporation-cogito/reviews